v3.26.1
Securities at amortized cost (AC)
12 Months Ended
Dec. 31, 2025
Financial Assets At Amortized Cost - Securities [Abstract]  
Securities at amortized cost (AC) Securities at amortized cost (AC)
The accounting policy on financial assets and liabilities is presented in Note 2c IV.
12/31/202512/31/2024
Gross book valueGross book value
Government securities126,693 158,680 
Brazil105,678 111,824 
Latin America5,974 21,730 
Abroad15,041 25,126 
Corporate securities193,458 168,827 
Rural product note69,778 60,358 
Bank deposit certificates63 50 
Real estate receivables certificates4,209 5,827 
Debentures79,168 77,344 
Eurobonds and other11,690 1,102 
Financial bills379 212 
Promissory and commercial notes21,359 16,312 
Other6,812 7,622 
Investment funds9,814 - 
Total329,965 327,507 
Expected credit loss(2,492)(3,655)
Amortized cost327,473 323,852 
The securities pledged as collateral for funding transactions with financial institutions and customers and post-employment benefits (Note 26b), are: a) Government securities - Brazil R$ 14,207 (R$ 39,289 at 12/31/2024) and b) Government securities – Latin America R$ 894 (R$ 969 at 12/31/2024 ) and c) Corporate securities R$ 378 (R$ 29,964 at 12/31/2024), totaling R$ 15,479 (R$ 70,222 at 12/31/2024).
Securities at amortized cost, by maturity:
12/31/202512/31/2024
Gross book valueAmortized costGross book valueAmortized cost
Current74,248 73,583 90,213 88,582 
Up to one year74,248 73,583 90,213 88,582 
Non-current255,717 253,890 237,294 235,270 
From one to five years189,524 187,986 165,759 164,332 
From five to ten years52,987 52,748 60,289 59,694 
After ten years13,206 13,156 11,246 11,244 
Total329,965 327,473 327,507 323,852 
Reconciliation of expected credit loss for securities at amortized cost, segregated by stages:
Stage 1Balance at
12/31/2024
Transfer to Stage 2Transfer to Stage 3Cure from Stage 2Cure from Stage 3(Increase) / ReversalWrite-offBalance at
12/31/2025
Government securities(28)20 (8)
Corporate securities(296)(10)46 (39)(1)62 (238)
Total(324)(10)46 (39)(1)82 - (246)
Stage 2Balance at
12/31/2024
Cure to Stage 1Transfer to Stage 3Transfer from Stage 1Cure from Stage 3(Increase) / ReversalWrite-offBalance at
12/31/2025
Corporate securities(125)39 175 10 (18)(842)(761)
Total(125)39 175 10 (18)(842)- (761)
Stage 3Balance at
12/31/2024
Cure to Stage 1Cure to Stage 2Transfer from Stage 1Transfer from Stage 2(Increase) / ReversalWrite-offBalance at
12/31/2025
Corporate securities(3,206)18 (46)(175)1,860 63 (1,485)
Total(3,206)1 18 (46)(175)1,860 63 (1,485)
Stage 1Balance at
12/31/2023
Transfer to Stage 2Transfer to Stage 3Cure from Stage 2Cure from Stage 3(Increase) / ReversalWrite-offBalance at
12/31/2024
Government securities(36)(28)
Corporate securities(147)449 149 (166)(88)(493)(296)
Total(183)449 149 (166)(88)(485)- (324)
Stage 2Balance at
12/31/2023
Cure to Stage 1Transfer to Stage 3Transfer from Stage 1Cure from Stage 3(Increase) / ReversalWrite-offBalance at
12/31/2024
Corporate securities(122)166 416 (449)(13)(123)(125)
Total(122)166 416 (449)(13)(123)- (125)
Stage 3Balance at
12/31/2023
Cure to Stage 1Cure to Stage 2Transfer from Stage 1Transfer from Stage 2(Increase) / ReversalWrite-offBalance at
12/31/2024
Corporate securities(549)88 13 (149)(416)(2,193)(3,206)
Total(549)88 13 (149)(416)(2,193)- (3,206)